CompletedPhase 3

Intravenous Lidocaine in Bariatric Surgery.

France180 participantsStarted 2017-12-01

Plain-language summary

Although peroperative intravenous lidocaine has been shown to be useful in early recovery after colorectal surgery, its beneficial effect on the specific population of obese patients scheduled for bariatric surgery remained unknown. Investigators hypothesized that peroperative intravenous lidocaine could decrease postoperative opioid consumption and improve postoperative recovery

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * scheduled bariatric surgery Exclusion Criteria: * any contra-indication for lidocaine administration * pregnancy * ASA class 4 * psychiatric disorder * chronic opioid consumption

What they're measuring

oxycodone consumption

Timeframe: three days following surgery

Trial details

NCT IDNCT03211455

SponsorUniversity Hospital, Caen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-02-01

View on ClinicalTrials.gov More Morbid Obesity trials